Cannabis Science Receives New Photos & Information on Patient Three’s Previous Examinations & the Current Progress on his S...
May 16 2012 - 2:37PM
Business Wire
Cannabis Science, Inc. (OTCBB:CBIS) a pioneering U.S. biotech
company developing pharmaceutical cannabis (marijuana) products, is
pleased to provide the latest photos and information on patient
three’s progress.
Cannabis Science continues to work closely with its third
patient, who is self-treating his otherwise resistant Squamous Cell
Carcinoma. The patient has seen dramatic improvements. He has been
applying a topical cannabis extract to his cancer, and has seen a
large reduction in the tumor masses. Dr. Melamede spoke with the
patient this morning, who stated that 80% of the rim that remained
from the large tumor on the left side of his head was now gone. The
newly posted photo was from over a week ago.
After his last visit to his oncologist (prior to the newly
posted photo), the physician explained that he is concerned there
may be more tumors on his head that have not yet manifested. The
oncologist then instructed the patient to apply the cannabis
extracts to his entire scalp. As a result of more extensive topical
application of the medicine, new areas have reemerged and are also
dying. For example, a new tumor emerged below his hairline. He
treated that tumor in the same manner as he has treated the others.
He reported that the new tumor had fallen off and left a small
hole, similar to what had occurred on his arm (we have not shown
these tumors). The rise and fall of the new tumor will be
photo-documented when we receive new photos.
Despite the severe pain resulting from additional exposed areas
as more tumor mass dies, he is happy to have chosen this route of
treatment as opposed to surgery that would have remove most of his
scalp and a good portion of the top of his skull. In order to help
with the pain and allow for better sleep, the patient is also now
taking the extract internally.
The patient stated, "As for my head... the oncologist was amazed
by the progress... as the one tumor on my right side is now
almost down to conforming with the natural shape of my head and he
thinks the others are being killed off too but predicted it
might be a couple more months before he could declare it
works... Cautious optimism. Also the doctor said that he is hopeful
that this works, as there is no known chemo that cures this
type of cancer."
You can view these new photos on the Cannabis Science website
www.cannabisscience.com and click the button “View Images of 3rd
Self-Medicated Patient & His Apparent Success.” You can read
more news on this 3rd patient as well on the Cannabis Science
website at www.cannabisscience.com and click on the breaking news
button where you will find all the cancer related and updated
patient news.
About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of pharmaceutical
grade medical marijuana research and development. The second
formulations will address the needs of patients choosing to use
concentrated cannabis extracts to treat their ailments. Eventually,
all Americans will have access to a safe and effective FDA approved
medicine regardless of which state they live in. To maintain that
marijuana is a dangerous, addictive drug with no medical value is
scientifically absurd. Cannabis medicines, with no effective lethal
dose, are far safer than aspirin, acetaminophen, and most other OTC
drugs that kill thousands of Americans every year.
The Company works with world authorities on phytocannabinoid
science targeting critical illnesses, and adheres to scientific
methodologies to develop, produce and commercialize
phytocannabinoid-based pharmaceutical products. In sum, we are
dedicated to the creation of cannabis-based medicines, both with
and without psychoactive properties, to treat disease and the
symptoms of disease, as well as for general health maintenance.
Forward Looking Statements
This Press Release includes forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Act of 1934. A statement containing
works such as "anticipate," "seek," intend," "believe," "plan,"
"estimate," "expect," "project," "plan," or similar phrases may be
deemed "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. Some or all of
the events or results anticipated by these forward-looking
statements may not occur. Factors that could cause or contribute to
such differences include the future U.S. and global economies, the
impact of competition, and the Company's reliance on existing
regulations regarding the use and development of cannabis-based
drugs. Cannabis Science, Inc. does not undertake any duty nor does
it intend to update the results of these forward-looking
statements.